2 completed, 2 unknown. 4 Phase 2.
By phase and status
Follow cavosonstat: new trials by email Literature Review of cavosonstat trials Research Report on cavosonstat
Trials (filtered) newest first · largest first
All 4 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Cavosonstat Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Subjects With Chronic Obstructive Pulmonary Disease (COPD) placebo, Cavosonstat 5 mg, Cavosonstat 10 mg - Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Unknown | 108 | 2021-02-03 | 2020-10-23 |
PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study MCT, Clazakizumab, Broncho-Vaxom - Asthma | Phase 2 | Completed | 950 | 2019-12-19 | 2026-04-01 |
Study of Cavosonstat (N91115) in CF Patients Who Are Heterozygous for F508del-CFTR and a Gating Mutation and Being Treated With Ivacaftor Cavosonstat, Placebo - Cystic Fibrosis | Phase 2 | Unknown | 19 | 2016-04-01 | 2016-11-21 |
Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation Cavosonstat, Placebo - Cystic Fibrosis | Phase 2 | Completed | 138 | 2015-11-01 | 2017-01-10 |
Conditions studied
Cystic Fibrosis (2) · Asthma (1) · Pulmonary Disease, Chronic Obstructive (1)
Sponsors
Nivalis Therapeutics, Inc. (2) · GSNOR Therapeutics, Inc. (1) · University of North Carolina, Chapel Hill (1)
Countries
United States (3)
Top investigators
Anastasia Ivanova, PhD (1) · James Chmiel, MD (1) · Scott Donaldson, MD (1)
NIH funding
U24HL138998 (1)